Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
Deepak L. Bhatt(Mount Sinai Hospital), Mark Napoli, Antonio Blanco, Kausik K. Ray(Imperial College London), Timothy J. Gardner(Uppsala University), Kim Fox(Royal Brompton Hospital), Alexander Parkhomenko, Jay Stone(Community Medical Center), Barry Bertolet, W. Herbert Haught, Ramin Manshadi, Dharam J. Kumbhani(Southwestern Medical Center), Ashit Jain, Irina Lendel, Khaled Nour(Wayne State University), Carlos Vaca(Ministerio de Salud), Louis Kantaros, Marielle Andersson(AstraZeneca (Sweden)), Dominick J. Angiolillo(University of Florida), Wilhelm Ridderstråle(AstraZeneca (Brazil)), Supratim Banerjee(Indian Institute of Science Education and Research Kolkata), R. Passi, Dustin Thomas, Francisco Padrón, Michael Pursley(The Heart House), Anders Himmelmänn(AstraZeneca (Sweden)), Mikhail Kosiborod(AstraZeneca (Brazil)), Satinder Saini, George Kichura, Harinder Gogia, Darren K. McGuire(Parkland Health & Hospital System), Stefan James(Uppsala University), Lawrence A. Leiter(St. Michael's Hospital), James Bennett, Amaury Roman-Miranda(Stanford University), Manuel Bouza, Claes Held(Uppsala University), Robert A Harrington(Center for Clinical Research (United States)), Tabassome Simon(Sorbonne Université), Yang Song(Baim Institute for Clinical Research), Shamir R Mehta(Population Health Research Institute), Wenwu Zhang, Robert Black, Michael D'Urso, Philippe Gabríel Steg(Mount Sinai Hospital), Michael Russo, Vladimir Santos
Cited by 212
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k